| pubmed-article:12629357 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0238033 | lld:lifeskim |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0751623 | lld:lifeskim |
| pubmed-article:12629357 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:12629357 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12629357 | pubmed:dateCreated | 2003-3-11 | lld:pubmed |
| pubmed-article:12629357 | pubmed:abstractText | Evaluation of second primary cancers provides valuable insight about etiology and shared risk factors. Studies of second primary cancers following prostate cancer conclude that overall risk of second primary cancers decreases. However, risk of bladder cancer and kidney cancer increases. We examine the risk of common and rare second primary cancers following prostate cancer in a large population based cohort to identify possible common etiological factors. | lld:pubmed |
| pubmed-article:12629357 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12629357 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12629357 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12629357 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12629357 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12629357 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:12629357 | pubmed:author | pubmed-author:GrönbergHenri... | lld:pubmed |
| pubmed-article:12629357 | pubmed:author | pubmed-author:MalmerBeatric... | lld:pubmed |
| pubmed-article:12629357 | pubmed:author | pubmed-author:ThellenbergCa... | lld:pubmed |
| pubmed-article:12629357 | pubmed:author | pubmed-author:TavelinBjörnB | lld:pubmed |
| pubmed-article:12629357 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12629357 | pubmed:volume | 169 | lld:pubmed |
| pubmed-article:12629357 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12629357 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12629357 | pubmed:pagination | 1345-8 | lld:pubmed |
| pubmed-article:12629357 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:meshHeading | pubmed-meshheading:12629357... | lld:pubmed |
| pubmed-article:12629357 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12629357 | pubmed:articleTitle | Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. | lld:pubmed |
| pubmed-article:12629357 | pubmed:affiliation | Department of Radiation Sciences, Oncology, Umeå University, Sweden. | lld:pubmed |
| pubmed-article:12629357 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12629357 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12629357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12629357 | lld:pubmed |
